210 related articles for article (PubMed ID: 32739350)
1. Generation of mWasabi fluorescent protein-binding nanobodies.
Li S; Shan H; Wang T; Zheng X; Shi M; Chen B; Lu H; Zhang Y; Zhao S; Hua Z
Anal Biochem; 2020 Nov; 608():113875. PubMed ID: 32739350
[TBL] [Abstract][Full Text] [Related]
2. Characterization of camel nanobodies specific for superfolder GFP fusion proteins.
Twair A; Al-Okla S; Zarkawi M; Abbady AQ
Mol Biol Rep; 2014 Oct; 41(10):6887-98. PubMed ID: 25085037
[TBL] [Abstract][Full Text] [Related]
3. Applications of Nanobodies.
Muyldermans S
Annu Rev Anim Biosci; 2021 Feb; 9():401-421. PubMed ID: 33233943
[TBL] [Abstract][Full Text] [Related]
4. Generation and characterization of nanobodies against rhGH expressed as sfGFP fusion protein.
Abbady AQ; Al-Shemali R; Mir Assaad J; Murad H
Gen Comp Endocrinol; 2014 Aug; 204():33-42. PubMed ID: 24859761
[TBL] [Abstract][Full Text] [Related]
5. A robust pipeline for rapid production of versatile nanobody repertoires.
Fridy PC; Li Y; Keegan S; Thompson MK; Nudelman I; Scheid JF; Oeffinger M; Nussenzweig MC; Fenyö D; Chait BT; Rout MP
Nat Methods; 2014 Dec; 11(12):1253-60. PubMed ID: 25362362
[TBL] [Abstract][Full Text] [Related]
6. Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii.
Payandeh Z; Rasooli I; Mousavi Gargari SL; Rajabi Bazl M; Ebrahimizadeh W
Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):92-8. PubMed ID: 24463583
[TBL] [Abstract][Full Text] [Related]
7. Selection and Characterization of Specific Nanobody Against Human Immunoglobulin G.
Kazemi-Lomedasht F; Behdani M; Rahimpour A; Habibi-Anbouhi M; Poshang-Bagheri K; Shahbazzadeh D
Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):201-5. PubMed ID: 26090598
[TBL] [Abstract][Full Text] [Related]
8. Generation, biochemical characterizations and validation of potent nanobodies derived from alpaca specific for human receptor of advanced glycation end product.
Mohammed A; Zeng W; Mengist HM; Kombe Kombe AJ; Ou H; Yang Y; Dan Z; Xu Z; Ma H; Jin T
Biochem Biophys Res Commun; 2021 Dec; 581():38-45. PubMed ID: 34653677
[TBL] [Abstract][Full Text] [Related]
9. Recombinant λ bacteriophage displaying nanobody towards third domain of HER-2 epitope inhibits proliferation of breast carcinoma SKBR-3 cell line.
Shoae-Hassani A; Mortazavi-Tabatabaei SA; Sharif S; Madadi S; Rezaei-Khaligh H; Verdi J
Arch Immunol Ther Exp (Warsz); 2013 Feb; 61(1):75-83. PubMed ID: 23224340
[TBL] [Abstract][Full Text] [Related]
10. Nanobodies derived from Camelids represent versatile biomolecules for biomedical applications.
Yu X; Xu Q; Wu Y; Jiang H; Wei W; Zulipikaer A; Guo Y; Jirimutu ; Chen J
Biomater Sci; 2020 Jul; 8(13):3559-3573. PubMed ID: 32490444
[TBL] [Abstract][Full Text] [Related]
11. [Preparation and identification of anti-follicle-stimulating hormone receptor nanobodies].
Xia X; M M; Zhai T; Li J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):829-33. PubMed ID: 23948408
[TBL] [Abstract][Full Text] [Related]
12. Streamlined method for parallel identification of single domain antibodies to membrane receptors on whole cells.
Rossotti M; Tabares S; Alfaya L; Leizagoyen C; Moron G; González-Sapienza G
Biochim Biophys Acta; 2015 Jul; 1850(7):1397-404. PubMed ID: 25819371
[TBL] [Abstract][Full Text] [Related]
13. Isolation of nanobodies against Xenopus embryonic antigens using immune and non-immune phage display libraries.
Itoh K; Reis AH; Hayhurst A; Sokol SY
PLoS One; 2019; 14(5):e0216083. PubMed ID: 31048885
[TBL] [Abstract][Full Text] [Related]
14. A guide to: generation and design of nanobodies.
Muyldermans S
FEBS J; 2021 Apr; 288(7):2084-2102. PubMed ID: 32780549
[TBL] [Abstract][Full Text] [Related]
15. High affinity nanobodies against human epidermal growth factor receptor selected on cells by E. coli display.
Salema V; Mañas C; Cerdán L; Piñero-Lambea C; Marín E; Roovers RC; Van Bergen En Henegouwen PM; Fernández LÁ
MAbs; 2016 Oct; 8(7):1286-1301. PubMed ID: 27472381
[TBL] [Abstract][Full Text] [Related]
16. Yeast surface display platform for rapid discovery of conformationally selective nanobodies.
McMahon C; Baier AS; Pascolutti R; Wegrecki M; Zheng S; Ong JX; Erlandson SC; Hilger D; Rasmussen SGF; Ring AM; Manglik A; Kruse AC
Nat Struct Mol Biol; 2018 Mar; 25(3):289-296. PubMed ID: 29434346
[TBL] [Abstract][Full Text] [Related]
17. A high affinity nanobody against endothelin receptor type B: a new approach to the treatment of melanoma.
Ji L; Dong C; Fan R; Qi S
Mol Biol Rep; 2020 Mar; 47(3):2137-2147. PubMed ID: 32080807
[TBL] [Abstract][Full Text] [Related]
18. Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies.
Romao E; Morales-Yanez F; Hu Y; Crauwels M; De Pauw P; Hassanzadeh GG; Devoogdt N; Ackaert C; Vincke C; Muyldermans S
Curr Pharm Des; 2016; 22(43):6500-6518. PubMed ID: 27669966
[TBL] [Abstract][Full Text] [Related]
19. Nanobody‑horseradish peroxidase and -EGFP fusions as reagents to detect porcine parvovirus in the immunoassays.
Lu Q; Li X; Zhao J; Zhu J; Luo Y; Duan H; Ji P; Wang K; Liu B; Wang X; Fan W; Sun Y; Zhou EM; Zhao Q
J Nanobiotechnology; 2020 Jan; 18(1):7. PubMed ID: 31910833
[TBL] [Abstract][Full Text] [Related]
20. Isolation of Camelid Single-Domain Antibodies Against Native Proteins Using Recombinant Multivalent Peptide Ligands.
Alturki NA; Henry KA; MacKenzie CR; Arbabi-Ghahroudi M
Methods Mol Biol; 2015; 1348():167-89. PubMed ID: 26424272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
